Navigation Links
Extra Tests Not a Deterrent to Experimental Cancer Therapy
Date:3/4/2011

FRIDAY, March 4 (HealthDay News) -- Cancer patients are willing to tolerate multiple needle pokes, X-rays, ultrasounds, PET and CT scans to receive advanced experimental treatments in early-stage clinical trials, with some even amenable to extra tumor biopsies, according to a new study.

The finding from interviews with 61 patients with advanced cancer suggests a promising future for personalized medicine, in which doctors use specific treatments based on the genetic makeup of patients' tumors.

The study, conducted by researchers at the Mayo Clinic, Scottsdale Healthcare and the Translational Genomics Research Institute in Arizona, appears online and in the July 15 print issue of the journal Cancer.

"This is the first study of its kind where patients themselves were asked what tests and medical imaging studies they would be willing to undergo while participating in clinical studies for their cancer. Patients also were asked how invasive they perceived such tests and studies [to be]," lead author Dr. Raoul Tibes, a physician-scientist for the Mayo Clinic in Arizona, said in a Translational Genomics Research Institute news release.

To gain a better understanding about the molecular aspects of cancer, scientists need to collect tumor samples and analyze images from tests such as CT, MRI and PET scans.

"What we learned is that patients are, in general, very willing to undergo additional, extra tests to participate in clinical studies," Tibes said.

The patients said they were most willing to undergo urine, blood, ultrasound, X-ray, echocardiogram, PET and CAT scan tests. They were least willing to undergo tumor and skin biopsies and MRIs. However, most patients were willing to give one tumor biopsy sample per study, and sometimes two per study.

"This is important information, because it tells us that we can design clinical studies that ask patients to give extra tumor biopsies. But we need to c
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Bitter melon extract attacks breast cancer cells
2. Bitter melon extract decreased breast cancer cell growth
3. Bitter Melon Extract May Slow, Stop Breast Cancer
4. Less Is More with the Innovation of Avemar(R) Fermented Wheat Germ Extract
5. Unique Equipment, Fun Workouts, Extraordinary Results
6. Green Tea Extract May Delay or Prevent Alzheimers
7. Tahitian Noni Extra Released With 16 Different Iridoids
8. Sunwin International & WILD Flavors Receive GRAS Letters of No Objection from FDA Validating Safety of Multiple Sunwin Stevia Extracts
9. Tahitian Noni Extra Sales Exceed Expectations
10. Abbey Color Inc. and Mexicana de Extractos International, S.A. de C.V. Announce Joint Venture Abbymex
11. Human Extracellular Matrix Significantly Improves Device Biocompatibility
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Extra Tests Not a Deterrent to Experimental Cancer Therapy
(Date:2/28/2015)... 28, 2015 A case management conference ... that have been filed by law firms including Bernstein ... in March, the Firm notes. , According to ... in the federal litigation will meet on March 13, ... prescription therapy treatments designed to raise levels of the ...
(Date:2/28/2015)... Toronto, ON (PRWEB) February 28, 2015 ... the Art of Facial Surgery was recently featured in ... 82 of the magazine, Dr. David Ellis was featured ... He discussed the various cosmetic enhancements that Kim Cattrall ... skin. , “Her forehead is smooth without horizontal ...
(Date:2/28/2015)... 28, 2015 Memphis, TN: MedixSafe has ... for a new security reader named Guardian 2. ... is a new biometric scanner that significantly increases ... features, the new biometric scanner provides fast and ... , MedixSafe narcotics lockers with Vanguard ...
(Date:2/27/2015)... Danvers, MA (PRWEB) February 27, 2015 ... enterprise mobility management services, and one of ... today announced support for Bell Mobility within their ... suite of services. Wireless Analytics’ newly developed ... and reporting for the Canadian wireless carrier’s business ...
(Date:2/27/2015)... 2015 Today, February 27th, is "Shine A ... along with LXR Organics and Living Fuel, ... to raise awareness and promote prevention, rescue and restoration for ... the END IT Coalition, slavery is the 2nd largest global ... in 167 countries around the world. Slavery includes bonded labor, ...
Breaking Medicine News(10 mins):Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:Dr. David Ellis Featured In Elevate Magazine 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 2Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 3Health News:KAJ Brothers Join the Campaign to 'End It - Shine A Light On Slavery' 2
... BETHESDA, Md. (May 1, 2009) − Medical science took ... that, at least temporarily, perform the function of vital ... machine and renal dialysis, require the blood to be ... known as extracorporeal circulation (EC) and have provided critical ...
... in the May 1 issue of the journal SLEEP ... more likely to suffer from significant sleep disturbances at 2 ... of the study are of particular importance, as sleep disturbances ... depression in childhood. , Results indicate that infants ...
... who are wounded in combat as the result of a ... develop an abnormality known as heterotopic ossification. In this condition, ... near a fracture or other bone injury. New research conducted ... helping to pave the way for a better understanding of ...
... President pro Tem Darrell Steinberg (D-Sacramento) today announced ... Autism (ASD) & Related Disorders which will build ... the three-year California Legislative Blue Ribbon ... by Steinberg and ended in November 2008. ...
... (NYSE: BKD ) announced today that it plans to ... on Wednesday, May 6, 2009. The Company has also scheduled ... 2009 at 10:00 AM ET. The conference call can be ... 634-9069 (from outside of the U.S.) ten minutes prior to the ...
... news updates, features live, daily call-in shows hosted by world-class ... Ten Swine Flu FAQs at www.sirius.com/doctorradio , NEW ... (Nasdaq: SIRI ) has begun regular live updates ... health and medical channel powered by NYU Langone Medical Center. ...
Cached Medicine News:Health News:Chemical can reproduce complications for some patients 2Health News:Chemical can reproduce complications for some patients 3Health News:Chemical can reproduce complications for some patients 4Health News:Chemical can reproduce complications for some patients 5Health News:Maternal depression is associated with significant sleep disturbance in infants 2Health News:Injured Marines at risk for abnormal bone growth 2Health News:Steinberg Announces Senate Select Committee on Autism and Related Disorders 2Health News:Brookdale Announces First Quarter 2009 Release and Earnings Call 2Health News:Swine Flu Epidemic Reported on by Doctors on SIRIUS XM's Doctor Radio Channel 2Health News:Swine Flu Epidemic Reported on by Doctors on SIRIUS XM's Doctor Radio Channel 3Health News:Swine Flu Epidemic Reported on by Doctors on SIRIUS XM's Doctor Radio Channel 4Health News:Swine Flu Epidemic Reported on by Doctors on SIRIUS XM's Doctor Radio Channel 5Health News:Swine Flu Epidemic Reported on by Doctors on SIRIUS XM's Doctor Radio Channel 6
(Date:2/27/2015)... 27, 2015  Acsis Inc., the market leader for ... today that John DiPalo , Acsis, Chief Strategy ... Demand Chain Executive 2015 Provider Pro to Know. ... initiatives to help prepare their companies, and customers, supply ... This year,s list of Provider Pros to Know is ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 /PRNewswire/ ... and Bloom Burton & Co. Ltd. ("Bloom Burton") today ... (the "Lock-Up") 2,353,130 common shares of the Company ("Common ... to the Lock-Up. Of the Common Shares released from ... upon release from the Lock-Up while the remainder will ...
(Date:2/27/2015)... 2015  In recognition of Rare Disease Day and ... bleeding disorders community, CSL Behring announced today ... of protein therapies to the World Federation of Hemophilia ... has worked to improve the lives of people with ... the WFH,s Global Alliance for Progress (GAP) Program aimed ...
Breaking Medicine Technology:Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3
... June 6, 2011 Bayer HealthCare Pharmaceuticals Inc. today ... in SYM ptomatic P rostate CA ... is exclusively licensed from Algeta ASA, in patients with ... primary endpoint by significantly improving overall survival.  Based on ...
... Executive Director of USA Swimming, was named this year,s ... in conjunction with the Wound, Ostomy and Continence Nurses ...  The Great Comebacks® Program, which provides support for people ... surgery, annually honors outstanding individuals who are inspiring others ...
Cached Medicine Technology:Bayer's Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone 2Bayer's Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone 3Great Comebacks® Program Recognizes National Award Winners 2Great Comebacks® Program Recognizes National Award Winners 3Great Comebacks® Program Recognizes National Award Winners 4Great Comebacks® Program Recognizes National Award Winners 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: